IBDEI0T6 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14119,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,14119,1,5,0)
 ;;=5^Neuropathy, peripheral, Hereditary; Unspecified
 ;;^UTILITY(U,$J,358.3,14119,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,14120,0)
 ;;=355.8^^74^861^8
 ;;^UTILITY(U,$J,358.3,14120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14120,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,14120,1,5,0)
 ;;=5^Neuropathy, peripheral, lower limb; Unspecified
 ;;^UTILITY(U,$J,358.3,14120,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,14121,0)
 ;;=356.2^^74^861^5
 ;;^UTILITY(U,$J,358.3,14121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14121,1,3,0)
 ;;=3^356.2
 ;;^UTILITY(U,$J,358.3,14121,1,5,0)
 ;;=5^Neuropathy, Hereditary sensory
 ;;^UTILITY(U,$J,358.3,14121,2)
 ;;=^56583
 ;;^UTILITY(U,$J,358.3,14122,0)
 ;;=714.0^^74^861^9
 ;;^UTILITY(U,$J,358.3,14122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14122,1,3,0)
 ;;=3^714.0
 ;;^UTILITY(U,$J,358.3,14122,1,5,0)
 ;;=5^Nodules, rheumatoid arthritis
 ;;^UTILITY(U,$J,358.3,14122,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,14123,0)
 ;;=733.82^^74^861^11
 ;;^UTILITY(U,$J,358.3,14123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14123,1,3,0)
 ;;=3^733.82
 ;;^UTILITY(U,$J,358.3,14123,1,5,0)
 ;;=5^Nonunion of fracture
 ;;^UTILITY(U,$J,358.3,14123,2)
 ;;=^83875
 ;;^UTILITY(U,$J,358.3,14124,0)
 ;;=173.70^^74^861^1
 ;;^UTILITY(U,$J,358.3,14124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14124,1,3,0)
 ;;=3^173.70
 ;;^UTILITY(U,$J,358.3,14124,1,5,0)
 ;;=5^Neoplasm, Skin Lower Limb
 ;;^UTILITY(U,$J,358.3,14124,2)
 ;;=^340603
 ;;^UTILITY(U,$J,358.3,14125,0)
 ;;=356.8^^74^861^6
 ;;^UTILITY(U,$J,358.3,14125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14125,1,3,0)
 ;;=3^356.8
 ;;^UTILITY(U,$J,358.3,14125,1,5,0)
 ;;=5^Neuropathy, Idiopathic Perip,Oth Spec
 ;;^UTILITY(U,$J,358.3,14125,2)
 ;;=^268525
 ;;^UTILITY(U,$J,358.3,14126,0)
 ;;=703.8^^74^861^10
 ;;^UTILITY(U,$J,358.3,14126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14126,1,3,0)
 ;;=3^703.8
 ;;^UTILITY(U,$J,358.3,14126,1,5,0)
 ;;=5^Nondystrophic Nails
 ;;^UTILITY(U,$J,358.3,14126,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,14127,0)
 ;;=703.0^^74^862^1
 ;;^UTILITY(U,$J,358.3,14127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14127,1,3,0)
 ;;=3^703.0
 ;;^UTILITY(U,$J,358.3,14127,1,5,0)
 ;;=5^Onychocryptosis (Ingrown toe nail)
 ;;^UTILITY(U,$J,358.3,14127,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,14128,0)
 ;;=757.5^^74^862^2
 ;;^UTILITY(U,$J,358.3,14128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14128,1,3,0)
 ;;=3^757.5
 ;;^UTILITY(U,$J,358.3,14128,1,5,0)
 ;;=5^Onchodystrophy/Onycholysis; Congenital
 ;;^UTILITY(U,$J,358.3,14128,2)
 ;;=^273090
 ;;^UTILITY(U,$J,358.3,14129,0)
 ;;=703.8^^74^862^3
 ;;^UTILITY(U,$J,358.3,14129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14129,1,3,0)
 ;;=3^703.8
 ;;^UTILITY(U,$J,358.3,14129,1,5,0)
 ;;=5^Onchodystrophy/Onycholysis; Acquired
 ;;^UTILITY(U,$J,358.3,14129,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,14130,0)
 ;;=110.1^^74^862^4
 ;;^UTILITY(U,$J,358.3,14130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14130,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,14130,1,5,0)
 ;;=5^Onychomycosis
 ;;^UTILITY(U,$J,358.3,14130,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,14131,0)
 ;;=715.37^^74^862^6
 ;;^UTILITY(U,$J,358.3,14131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14131,1,3,0)
 ;;=3^715.37
 ;;^UTILITY(U,$J,358.3,14131,1,5,0)
 ;;=5^Osteoarthrosis, localized, not specified whether primary or secondary; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,14131,2)
 ;;=^272156
 ;;^UTILITY(U,$J,358.3,14132,0)
 ;;=715.90^^74^862^7
 ;;^UTILITY(U,$J,358.3,14132,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0T6
